Cargando…
De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995
BACKGROUND: Advances in breast cancer (BC) care have reduced mortality, but their impact on survival once diagnosed with metastasis is less well described. This systematic review aimed to describe population-level survival since 1995 for de novo metastatic BC (dnMBC) and recurrent MBC (rMBC). METHOD...
Autores principales: | Lord, SJ, Bahlmann, K, O'Connell, DL, Kiely, BE, Daniels, B, Pearson, SA, Beith, J, Bulsara, MK, Houssami, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804182/ https://www.ncbi.nlm.nih.gov/pubmed/35128368 http://dx.doi.org/10.1016/j.eclinm.2022.101282 |
Ejemplares similares
-
Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol
por: Lord, Sarah J, et al.
Publicado: (2019) -
Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study
por: Lord, Sarah (Sally) J, et al.
Publicado: (2022) -
Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort
por: Daniels, Benjamin, et al.
Publicado: (2021) -
Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)
por: Daniels, Benjamin, et al.
Publicado: (2018) -
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)
por: Daniels, Benjamin, et al.
Publicado: (2018)